|
Albumin or Saline?
|
In patients in the ICU, use of
either 4% albumin or normal saline for fluid resuscitation results in
similar outcomes at 28 days.
Level of Evidence: 1++ |
Citation/s:
The SAFE study investigators, A comparison of albumin and saline for fluid
resuscitation in the intensive care unit. N Engl J Med 2004;350:2247-56
Lead author's name and fax: Dr S Finfer at ANZICS.
ctg@anzics.com.au
Three-part Clinical Question: Is the use of 4% albumin solution for
intravascular resuscitation in intensive care patients associated with a higher
mortality when compared with 0.9% saline.
Search Terms: intensive care, resuscitation, fluid, saline, albumin
The Study: Double-blinded concealed randomised controlled trial without
intention-to-treat.
The Study Patients: 16 ICUs. Age >18. Patients admitted to the ICU after
cardiac surgery, after liver transplantation or after the treatment of burns
were excluded. Random assignments stratified according to institution and
according to whether there was a diagnosis of trauma or not. In addition to the
study fluids patients receives, enteral nutrition, TPN, blood products,
maintenance fluids and specific replacement fluids at the discretion of the
treating physician.
Control group (N = 3501; 3460 analysed): 0.9% Sodium Chloride solution
for intravascular resuscitation until death, discharge or 28 days after
randomization.
Experimental group (N = 3499; 3473 analysed): 4% Albumin solution for
intravascular resuscitation until death, discharge or 28 days after
randomization.
The Evidence:
|
Outcome |
Time to Outcome |
CER |
EER |
RRR |
ARR |
NNT |
|
Death |
28 days |
0.208 |
0.207 |
0% |
0.001 |
1000 |
|
95% Confidence Intervals: |
-9% to 10% |
-0.018 to 0.020 |
NNT = 50 to INF; NNH = 56 to INF |
Comments:
Large well conducted study. No difference in organ failure. Larger volumes
administered in the saline group over the first 2 days. More blood administered
in the albumin group in the first 2 days. Marginal increase in mortality in
trauma patients, with brain injuries, and a decrease in mortality in septic
patients, managed with albumin although the study was not designed or powered to
determine whether these differences were real.
EBM questions:
1) Do the methods allow accurate testing of the hypothesis? Yes
2) Do the statistical tests correctly test the results to allow differentiation
of statistically significant results? Yes
3) Are conclusions valid in light of the results? Yes “In patients in the ICU,
use of either 4 percent albumin or normal saline for fluid resuscitation results
in similar outcomes at 28 days.”
4) Did results get omitted, and why? No
5) Did they suggest areas of further research? Yes. Further study of more
selected patient populations.
6) Did they make any recommendations based on the results and were they
appropriate? Yes “factors which may influence the choice of resuscitation fluid
for the critically ill patient include the individual clinician’s preference,
the tolerability of the treatment, its safety, and its cost.”
7) Is the study relevant to my clinical practice? Yes
8) What level of evidence does this
study represent? 1++
9) What grade of recommendation
can I make on this result alone? A
10) What grade of recommendation
can I make when this study is considered along with other available evidence? A
11) Should I change my practice because of these results? Possibly, if you have
a local policy which favours one of these fluids, your reasons should be
reviewed.
12) Should I audit my current practice because of these results? Yes, if
currently there is a local policy favouring one of these fluids, it should be
reviewed.
Appraised by: Dr Chris Cairns. SICS EBM group. ; Friday, June 04, 2004
Email: Chris.Cairns@btinternet.com
Kill or Update By: June 2008
Printer Friendly
Format
|